nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrosine—TH—prostate cancer	0.77	1	CbGaD
Metyrosine—TH—p38 signaling mediated by MAPKAP kinases—ETV1—prostate cancer	0.0123	0.122	CbGpPWpGaD
Metyrosine—TH—Dopaminergic Neurogenesis—ASCL1—prostate cancer	0.00404	0.04	CbGpPWpGaD
Metyrosine—TH—Dopamine metabolism—PRKACB—prostate cancer	0.0032	0.0317	CbGpPWpGaD
Metyrosine—TH—Biogenic Amine Synthesis—ACHE—prostate cancer	0.00299	0.0296	CbGpPWpGaD
Metyrosine—TH—Dopamine metabolism—NQO1—prostate cancer	0.00278	0.0276	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—HBG2—prostate cancer	0.00264	0.0261	CbGpPWpGaD
Metyrosine—TH—Amine-derived hormones—SLC5A5—prostate cancer	0.00244	0.0242	CbGpPWpGaD
Metyrosine—TH—Dopamine metabolism—COMT—prostate cancer	0.00233	0.0231	CbGpPWpGaD
Metyrosine—TH—Biogenic Amine Synthesis—COMT—prostate cancer	0.00208	0.0206	CbGpPWpGaD
Metyrosine—TH—Alpha-synuclein signaling—PLCB2—prostate cancer	0.00207	0.0205	CbGpPWpGaD
Metyrosine—TH—Parkinsons Disease Pathway—CASP6—prostate cancer	0.00192	0.019	CbGpPWpGaD
Metyrosine—TH—Monoamine Transport—ACHE—prostate cancer	0.00163	0.0161	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—NKX3-1—prostate cancer	0.0016	0.0158	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—ZFHX3—prostate cancer	0.00153	0.0152	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—MT2A—prostate cancer	0.00139	0.0138	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—HAO1—prostate cancer	0.00138	0.0136	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—PENK—prostate cancer	0.00132	0.0131	CbGpPWpGaD
Metyrosine—Acetaminophen—SULT1E1—prostate cancer	0.00127	0.174	CrCbGaD
Metyrosine—TH—Parkinsons Disease Pathway—CASP9—prostate cancer	0.00112	0.0111	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—ADI1—prostate cancer	0.00112	0.0111	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—PSAT1—prostate cancer	0.00112	0.0111	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—CSAD—prostate cancer	0.00112	0.0111	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—TST—prostate cancer	0.00112	0.0111	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—ATF3—prostate cancer	0.00109	0.0108	CbGpPWpGaD
Metyrosine—Acetaminophen—SULT1A1—prostate cancer	0.00108	0.148	CrCbGaD
Metyrosine—Acetaminophen—SULT2A1—prostate cancer	0.00108	0.148	CrCbGaD
Metyrosine—TH—SIDS Susceptibility Pathways—ASCL1—prostate cancer	0.00108	0.0107	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—GRHPR—prostate cancer	0.00104	0.0103	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—CKMT2—prostate cancer	0.00104	0.0103	CbGpPWpGaD
Metyrosine—Acetaminophen—UGT2B15—prostate cancer	0.00102	0.139	CrCbGaD
Metyrosine—TH—AP-1 transcription factor network—NPPA—prostate cancer	0.001	0.00991	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—ACHE—prostate cancer	0.000998	0.00989	CbGpPWpGaD
Metyrosine—TH—Monoamine Transport—ITGB3—prostate cancer	0.000983	0.00974	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—ATF3—prostate cancer	0.000948	0.00939	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—NAGLU—prostate cancer	0.00093	0.00921	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—GADD45A—prostate cancer	0.000873	0.00865	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—ID3—prostate cancer	0.000841	0.00833	CbGpPWpGaD
Metyrosine—TH—Alpha-synuclein signaling—BAD—prostate cancer	0.000816	0.00808	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—BRCA1—prostate cancer	0.000748	0.00741	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—MTAP—prostate cancer	0.000723	0.00716	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	0.000696	0.00689	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—EGR1—prostate cancer	0.000672	0.00665	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—ARG2—prostate cancer	0.000644	0.00638	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—PHGDH—prostate cancer	0.000644	0.00638	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—GJA1—prostate cancer	0.00064	0.00634	CbGpPWpGaD
Metyrosine—L-Tyrosine—TH—prostate cancer	0.000624	0.0854	CrCbGaD
Metyrosine—TH—AP-1 transcription factor network—IL10—prostate cancer	0.000555	0.00549	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—BCL2L1—prostate cancer	0.000538	0.00533	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—PLAU—prostate cancer	0.000531	0.00526	CbGpPWpGaD
Metyrosine—Acetaminophen—NAT2—prostate cancer	0.000528	0.0723	CrCbGaD
Metyrosine—TH—Circadian rythm related genes—HNF1B—prostate cancer	0.000519	0.00515	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—NR3C1—prostate cancer	0.000513	0.00508	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—ESR1—prostate cancer	0.0005	0.00495	CbGpPWpGaD
Metyrosine—TH—Alpha-synuclein signaling—SRC—prostate cancer	0.000485	0.00481	CbGpPWpGaD
Metyrosine—TH—Dopaminergic Neurogenesis—STAT3—prostate cancer	0.00048	0.00476	CbGpPWpGaD
Metyrosine—TH—Parkinsons Disease Pathway—CASP3—prostate cancer	0.000473	0.00469	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—HIF1A—prostate cancer	0.000467	0.00463	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—PRKDC—prostate cancer	0.000463	0.00459	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—PLAU—prostate cancer	0.000463	0.00458	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—INS—prostate cancer	0.000447	0.00443	CbGpPWpGaD
Metyrosine—TH—Dopaminergic Neurogenesis—TGFB1—prostate cancer	0.000445	0.00441	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—AHR—prostate cancer	0.000442	0.00437	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—PRKACB—prostate cancer	0.000439	0.00434	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—ESR1—prostate cancer	0.000436	0.00432	CbGpPWpGaD
Metyrosine—Methyldopa—COMT—prostate cancer	0.000423	0.0579	CrCbGaD
Metyrosine—TH—ATF-2 transcription factor network—MMP2—prostate cancer	0.000418	0.00414	CbGpPWpGaD
Metyrosine—Vomiting—Estramustine—prostate cancer	0.000414	0.00341	CcSEcCtD
Metyrosine—Asthenia—Flutamide—prostate cancer	0.000413	0.0034	CcSEcCtD
Metyrosine—Swelling—Etoposide—prostate cancer	0.000411	0.00339	CcSEcCtD
Metyrosine—Urticaria—Degarelix—prostate cancer	0.00041	0.00338	CcSEcCtD
Metyrosine—Thrombocytopenia—Bicalutamide—prostate cancer	0.000408	0.00336	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—IL1RN—prostate cancer	0.000408	0.00404	CbGpPWpGaD
Metyrosine—Abdominal pain—Degarelix—prostate cancer	0.000408	0.00336	CcSEcCtD
Metyrosine—Headache—Estramustine—prostate cancer	0.000408	0.00336	CcSEcCtD
Metyrosine—Oedema peripheral—Goserelin—prostate cancer	0.000402	0.00331	CcSEcCtD
Metyrosine—Vomiting—Abiraterone—prostate cancer	0.000402	0.00331	CcSEcCtD
Metyrosine—Feeling abnormal—Cabazitaxel—prostate cancer	0.000401	0.0033	CcSEcCtD
Metyrosine—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.0004	0.00329	CcSEcCtD
Metyrosine—Oedema peripheral—Conjugated Estrogens—prostate cancer	0.000399	0.00328	CcSEcCtD
Metyrosine—Gastrointestinal pain—Cabazitaxel—prostate cancer	0.000398	0.00328	CcSEcCtD
Metyrosine—Vomiting—Estrone—prostate cancer	0.000396	0.00326	CcSEcCtD
Metyrosine—Diarrhoea—Nilutamide—prostate cancer	0.000395	0.00326	CcSEcCtD
Metyrosine—Diarrhoea—Flutamide—prostate cancer	0.000394	0.00324	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Mitoxantrone—prostate cancer	0.000393	0.00323	CcSEcCtD
Metyrosine—Headache—Estrone—prostate cancer	0.00039	0.00321	CcSEcCtD
Metyrosine—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.00039	0.00321	CcSEcCtD
Metyrosine—Nausea—Estramustine—prostate cancer	0.000387	0.00319	CcSEcCtD
Metyrosine—Abdominal pain—Cabazitaxel—prostate cancer	0.000384	0.00317	CcSEcCtD
Metyrosine—Hypersensitivity—Degarelix—prostate cancer	0.00038	0.00313	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—ESR2—prostate cancer	0.000378	0.00375	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—BCL2—prostate cancer	0.000377	0.00374	CbGpPWpGaD
Metyrosine—Insomnia—Bicalutamide—prostate cancer	0.000377	0.00311	CcSEcCtD
Metyrosine—Asthenia—Degarelix—prostate cancer	0.00037	0.00305	CcSEcCtD
Metyrosine—Nausea—Estrone—prostate cancer	0.00037	0.00304	CcSEcCtD
Metyrosine—Vomiting—Nilutamide—prostate cancer	0.000367	0.00303	CcSEcCtD
Metyrosine—Anxiety—Ethinyl Estradiol—prostate cancer	0.000367	0.00302	CcSEcCtD
Metyrosine—Vomiting—Flutamide—prostate cancer	0.000366	0.00301	CcSEcCtD
Metyrosine—Headache—Nilutamide—prostate cancer	0.000362	0.00298	CcSEcCtD
Metyrosine—Headache—Flutamide—prostate cancer	0.00036	0.00297	CcSEcCtD
Metyrosine—Fatigue—Bicalutamide—prostate cancer	0.00036	0.00296	CcSEcCtD
Metyrosine—Hypersensitivity—Cabazitaxel—prostate cancer	0.000358	0.00295	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—EGR1—prostate cancer	0.000354	0.00351	CbGpPWpGaD
Metyrosine—Diarrhoea—Degarelix—prostate cancer	0.000353	0.00291	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—TOP2A—prostate cancer	0.000351	0.00348	CbGpPWpGaD
Metyrosine—Asthenia—Cabazitaxel—prostate cancer	0.000349	0.00287	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—CXCL8—prostate cancer	0.000348	0.00344	CbGpPWpGaD
Metyrosine—Erectile dysfunction—Mitoxantrone—prostate cancer	0.000347	0.00286	CcSEcCtD
Metyrosine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000345	0.00284	CcSEcCtD
Metyrosine—Haematuria—Estradiol—prostate cancer	0.000344	0.00283	CcSEcCtD
Metyrosine—Feeling abnormal—Bicalutamide—prostate cancer	0.000344	0.00283	CcSEcCtD
Metyrosine—Nausea—Nilutamide—prostate cancer	0.000343	0.00283	CcSEcCtD
Metyrosine—Swelling—Docetaxel—prostate cancer	0.000342	0.00281	CcSEcCtD
Metyrosine—Nausea—Flutamide—prostate cancer	0.000342	0.00281	CcSEcCtD
Metyrosine—Gastrointestinal pain—Bicalutamide—prostate cancer	0.000341	0.00281	CcSEcCtD
Metyrosine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00034	0.0028	CcSEcCtD
Metyrosine—TH—Amino acid and derivative metabolism—SLC5A5—prostate cancer	0.00034	0.00337	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—NCOA2—prostate cancer	0.000338	0.00335	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—GJA1—prostate cancer	0.000337	0.00334	CbGpPWpGaD
Metyrosine—Blood disorder—Epirubicin—prostate cancer	0.000335	0.00276	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—AR—prostate cancer	0.000334	0.00331	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—EZH2—prostate cancer	0.000333	0.0033	CbGpPWpGaD
Metyrosine—Diarrhoea—Cabazitaxel—prostate cancer	0.000333	0.00274	CcSEcCtD
Metyrosine—Urticaria—Bicalutamide—prostate cancer	0.000331	0.00273	CcSEcCtD
Metyrosine—Swelling—Capecitabine—prostate cancer	0.000331	0.00273	CcSEcCtD
Metyrosine—Abdominal pain—Bicalutamide—prostate cancer	0.00033	0.00272	CcSEcCtD
Metyrosine—Anaemia—Goserelin—prostate cancer	0.000329	0.00271	CcSEcCtD
Metyrosine—TH—Amino acid and derivative metabolism—NQO1—prostate cancer	0.000328	0.00325	CbGpPWpGaD
Metyrosine—Vomiting—Degarelix—prostate cancer	0.000328	0.0027	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—CCND1—prostate cancer	0.000324	0.00321	CbGpPWpGaD
Metyrosine—Headache—Degarelix—prostate cancer	0.000323	0.00266	CcSEcCtD
Metyrosine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000323	0.00266	CcSEcCtD
Metyrosine—Haematuria—Mitoxantrone—prostate cancer	0.00032	0.00264	CcSEcCtD
Metyrosine—Oedema peripheral—Estradiol—prostate cancer	0.000319	0.00263	CcSEcCtD
Metyrosine—Blood disorder—Doxorubicin—prostate cancer	0.00031	0.00256	CcSEcCtD
Metyrosine—Vomiting—Cabazitaxel—prostate cancer	0.000309	0.00255	CcSEcCtD
Metyrosine—Hypersensitivity—Bicalutamide—prostate cancer	0.000307	0.00253	CcSEcCtD
Metyrosine—Nausea—Degarelix—prostate cancer	0.000307	0.00253	CcSEcCtD
Metyrosine—Headache—Cabazitaxel—prostate cancer	0.000305	0.00251	CcSEcCtD
Metyrosine—Fatigue—Ethinyl Estradiol—prostate cancer	0.000304	0.0025	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CXCL8—prostate cancer	0.000303	0.003	CbGpPWpGaD
Metyrosine—Anxiety—Goserelin—prostate cancer	0.000302	0.00248	CcSEcCtD
Metyrosine—Asthenia—Bicalutamide—prostate cancer	0.000299	0.00247	CcSEcCtD
Metyrosine—Anxiety—Conjugated Estrogens—prostate cancer	0.000299	0.00246	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—EP300—prostate cancer	0.000298	0.00295	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—CDKN1B—prostate cancer	0.000296	0.00293	CbGpPWpGaD
Metyrosine—Dry mouth—Goserelin—prostate cancer	0.000296	0.00244	CcSEcCtD
Metyrosine—Confusional state—Goserelin—prostate cancer	0.000293	0.00241	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000292	0.00289	CbGpPWpGaD
Metyrosine—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000291	0.00239	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—IL2—prostate cancer	0.00029	0.00287	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—EGR1—prostate cancer	0.000289	0.00286	CbGpPWpGaD
Metyrosine—Nausea—Cabazitaxel—prostate cancer	0.000289	0.00238	CcSEcCtD
Metyrosine—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.000288	0.00237	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—NGFR—prostate cancer	0.000287	0.00284	CbGpPWpGaD
Metyrosine—Diarrhoea—Bicalutamide—prostate cancer	0.000285	0.00235	CcSEcCtD
Metyrosine—Thrombocytopenia—Goserelin—prostate cancer	0.000284	0.00234	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CCND1—prostate cancer	0.000283	0.0028	CbGpPWpGaD
Metyrosine—Urticaria—Ethinyl Estradiol—prostate cancer	0.00028	0.00231	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CTNNB1—prostate cancer	0.00028	0.00277	CbGpPWpGaD
Metyrosine—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000279	0.0023	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—MMP9—prostate cancer	0.000274	0.00272	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—PTEN—prostate cancer	0.000273	0.0027	CbGpPWpGaD
Metyrosine—Salivary hypersecretion—Epirubicin—prostate cancer	0.000272	0.00224	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Docetaxel—prostate cancer	0.000271	0.00224	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.00027	0.00268	CbGpPWpGaD
Metyrosine—Vomiting—Bicalutamide—prostate cancer	0.000265	0.00218	CcSEcCtD
Metyrosine—Tremor—Estradiol—prostate cancer	0.000264	0.00218	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Capecitabine—prostate cancer	0.000263	0.00216	CcSEcCtD
Metyrosine—Insomnia—Goserelin—prostate cancer	0.000262	0.00216	CcSEcCtD
Metyrosine—Headache—Bicalutamide—prostate cancer	0.000261	0.00215	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—EP300—prostate cancer	0.00026	0.00258	CbGpPWpGaD
Metyrosine—Insomnia—Conjugated Estrogens—prostate cancer	0.00026	0.00214	CcSEcCtD
Metyrosine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00026	0.00214	CcSEcCtD
Metyrosine—Asthenia—Ethinyl Estradiol—prostate cancer	0.000253	0.00208	CcSEcCtD
Metyrosine—TH—Metabolism—HAO1—prostate cancer	0.000253	0.0025	CbGpPWpGaD
Metyrosine—Salivary hypersecretion—Doxorubicin—prostate cancer	0.000252	0.00207	CcSEcCtD
Metyrosine—Fatigue—Goserelin—prostate cancer	0.00025	0.00206	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—SIRT1—prostate cancer	0.000249	0.00246	CbGpPWpGaD
Metyrosine—Fatigue—Conjugated Estrogens—prostate cancer	0.000248	0.00204	CcSEcCtD
Metyrosine—Nausea—Bicalutamide—prostate cancer	0.000248	0.00204	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.000246	0.00244	CbGpPWpGaD
Metyrosine—Anaemia—Mitoxantrone—prostate cancer	0.000243	0.002	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—TYMS—prostate cancer	0.000241	0.00239	CbGpPWpGaD
Metyrosine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000241	0.00199	CcSEcCtD
Metyrosine—Anxiety—Estradiol—prostate cancer	0.000239	0.00197	CcSEcCtD
Metyrosine—Feeling abnormal—Goserelin—prostate cancer	0.000239	0.00197	CcSEcCtD
Metyrosine—Ibuprofen—BCL2—prostate cancer	0.000238	0.0326	CrCbGaD
Metyrosine—Gastrointestinal pain—Goserelin—prostate cancer	0.000237	0.00195	CcSEcCtD
Metyrosine—Dysuria—Capecitabine—prostate cancer	0.000236	0.00194	CcSEcCtD
Metyrosine—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000235	0.00194	CcSEcCtD
Metyrosine—Dry mouth—Estradiol—prostate cancer	0.000235	0.00193	CcSEcCtD
Metyrosine—Confusional state—Estradiol—prostate cancer	0.000232	0.00191	CcSEcCtD
Metyrosine—Urticaria—Goserelin—prostate cancer	0.000231	0.0019	CcSEcCtD
Metyrosine—Abdominal pain—Goserelin—prostate cancer	0.000229	0.00189	CcSEcCtD
Metyrosine—Urticaria—Conjugated Estrogens—prostate cancer	0.000228	0.00188	CcSEcCtD
Metyrosine—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000227	0.00187	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—MYC—prostate cancer	0.000227	0.00224	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—TGFB1—prostate cancer	0.000226	0.00224	CbGpPWpGaD
Metyrosine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000224	0.00185	CcSEcCtD
Metyrosine—Anxiety—Mitoxantrone—prostate cancer	0.000223	0.00184	CcSEcCtD
Metyrosine—Headache—Ethinyl Estradiol—prostate cancer	0.000221	0.00182	CcSEcCtD
Metyrosine—Confusional state—Mitoxantrone—prostate cancer	0.000216	0.00178	CcSEcCtD
Metyrosine—Haematuria—Capecitabine—prostate cancer	0.000214	0.00177	CcSEcCtD
Metyrosine—Acetaminophen—CYP2A6—prostate cancer	0.000214	0.0293	CrCbGaD
Metyrosine—Hypersensitivity—Goserelin—prostate cancer	0.000214	0.00176	CcSEcCtD
Metyrosine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000212	0.00174	CcSEcCtD
Metyrosine—Thrombocytopenia—Mitoxantrone—prostate cancer	0.00021	0.00173	CcSEcCtD
Metyrosine—Nausea—Ethinyl Estradiol—prostate cancer	0.000209	0.00172	CcSEcCtD
Metyrosine—Asthenia—Goserelin—prostate cancer	0.000208	0.00171	CcSEcCtD
Metyrosine—Insomnia—Estradiol—prostate cancer	0.000208	0.00171	CcSEcCtD
Metyrosine—Erectile dysfunction—Prednisone—prostate cancer	0.000207	0.0017	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—PPARA—prostate cancer	0.000207	0.00205	CbGpPWpGaD
Metyrosine—Asthenia—Conjugated Estrogens—prostate cancer	0.000206	0.0017	CcSEcCtD
Metyrosine—TH—Metabolism—CBR1—prostate cancer	0.000206	0.00204	CbGpPWpGaD
Metyrosine—TH—Metabolism—CSAD—prostate cancer	0.000206	0.00204	CbGpPWpGaD
Metyrosine—TH—Metabolism—ADI1—prostate cancer	0.000206	0.00204	CbGpPWpGaD
Metyrosine—TH—Metabolism—TST—prostate cancer	0.000206	0.00204	CbGpPWpGaD
Metyrosine—TH—Metabolism—PSAT1—prostate cancer	0.000206	0.00204	CbGpPWpGaD
Metyrosine—TH—Metabolism—GRHL1—prostate cancer	0.000206	0.00204	CbGpPWpGaD
Metyrosine—Oedema peripheral—Docetaxel—prostate cancer	0.000205	0.00169	CcSEcCtD
Metyrosine—Anaemia—Etoposide—prostate cancer	0.000202	0.00166	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000201	0.00199	CbGpPWpGaD
Metyrosine—Oedema peripheral—Capecitabine—prostate cancer	0.000199	0.00164	CcSEcCtD
Metyrosine—Diarrhoea—Goserelin—prostate cancer	0.000199	0.00164	CcSEcCtD
Metyrosine—Fatigue—Estradiol—prostate cancer	0.000198	0.00163	CcSEcCtD
Metyrosine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000197	0.00162	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—LEP—prostate cancer	0.000196	0.00194	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—IL6—prostate cancer	0.000195	0.00193	CbGpPWpGaD
Metyrosine—TH—Metabolism—CKMT2—prostate cancer	0.000192	0.0019	CbGpPWpGaD
Metyrosine—TH—Metabolism—GRHPR—prostate cancer	0.000192	0.0019	CbGpPWpGaD
Metyrosine—TH—Metabolism—UGT2B15—prostate cancer	0.000192	0.0019	CbGpPWpGaD
Metyrosine—TH—Metabolism—UGT2B17—prostate cancer	0.000192	0.0019	CbGpPWpGaD
Metyrosine—Ibuprofen—CXCL8—prostate cancer	0.000191	0.0261	CrCbGaD
Metyrosine—Feeling abnormal—Estradiol—prostate cancer	0.00019	0.00156	CcSEcCtD
Metyrosine—Gastrointestinal pain—Estradiol—prostate cancer	0.000188	0.00155	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—TP53—prostate cancer	0.000186	0.00184	CbGpPWpGaD
Metyrosine—Fatigue—Mitoxantrone—prostate cancer	0.000185	0.00152	CcSEcCtD
Metyrosine—Vomiting—Goserelin—prostate cancer	0.000185	0.00152	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Epirubicin—prostate cancer	0.000183	0.00151	CcSEcCtD
Metyrosine—Vomiting—Conjugated Estrogens—prostate cancer	0.000183	0.00151	CcSEcCtD
Metyrosine—Urticaria—Estradiol—prostate cancer	0.000183	0.00151	CcSEcCtD
Metyrosine—Abdominal pain—Estradiol—prostate cancer	0.000182	0.0015	CcSEcCtD
Metyrosine—Headache—Goserelin—prostate cancer	0.000182	0.0015	CcSEcCtD
Metyrosine—TH—Metabolism—PGAM2—prostate cancer	0.00018	0.00178	CbGpPWpGaD
Metyrosine—TH—Metabolism—NAGLU—prostate cancer	0.00018	0.00178	CbGpPWpGaD
Metyrosine—TH—Metabolism—SULT2B1—prostate cancer	0.00018	0.00178	CbGpPWpGaD
Metyrosine—TH—Metabolism—MBTPS1—prostate cancer	0.00018	0.00178	CbGpPWpGaD
Metyrosine—TH—Metabolism—RFK—prostate cancer	0.00018	0.00178	CbGpPWpGaD
Metyrosine—TH—Metabolism—AOX1—prostate cancer	0.00018	0.00178	CbGpPWpGaD
Metyrosine—TH—Metabolism—GSTM3—prostate cancer	0.00018	0.00178	CbGpPWpGaD
Metyrosine—Headache—Conjugated Estrogens—prostate cancer	0.00018	0.00148	CcSEcCtD
Metyrosine—Confusional state—Etoposide—prostate cancer	0.00018	0.00148	CcSEcCtD
Metyrosine—Hallucination—Prednisone—prostate cancer	0.000179	0.00147	CcSEcCtD
Metyrosine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000177	0.00145	CcSEcCtD
Metyrosine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000175	0.00144	CcSEcCtD
Metyrosine—Thrombocytopenia—Etoposide—prostate cancer	0.000175	0.00144	CcSEcCtD
Metyrosine—Eosinophilia—Epirubicin—prostate cancer	0.000174	0.00143	CcSEcCtD
Metyrosine—Nausea—Goserelin—prostate cancer	0.000172	0.00142	CcSEcCtD
Metyrosine—TH—Metabolism—NAT1—prostate cancer	0.000171	0.00169	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP3A43—prostate cancer	0.000171	0.00169	CbGpPWpGaD
Metyrosine—TH—Metabolism—SRD5A2—prostate cancer	0.000171	0.00169	CbGpPWpGaD
Metyrosine—TH—Metabolism—AMACR—prostate cancer	0.000171	0.00169	CbGpPWpGaD
Metyrosine—TH—Metabolism—DEGS1—prostate cancer	0.000171	0.00169	CbGpPWpGaD
Metyrosine—Nausea—Conjugated Estrogens—prostate cancer	0.000171	0.00141	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—IL6—prostate cancer	0.00017	0.00169	CbGpPWpGaD
Metyrosine—Urticaria—Mitoxantrone—prostate cancer	0.00017	0.0014	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—GSK3B—prostate cancer	0.00017	0.00168	CbGpPWpGaD
Metyrosine—Hypersensitivity—Estradiol—prostate cancer	0.000169	0.0014	CcSEcCtD
Metyrosine—Abdominal pain—Mitoxantrone—prostate cancer	0.000169	0.0014	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	0.000169	0.0014	CcSEcCtD
Metyrosine—Anaemia—Docetaxel—prostate cancer	0.000168	0.00138	CcSEcCtD
Metyrosine—Asthenia—Estradiol—prostate cancer	0.000165	0.00136	CcSEcCtD
Metyrosine—Tremor—Capecitabine—prostate cancer	0.000165	0.00136	CcSEcCtD
Metyrosine—Dysuria—Epirubicin—prostate cancer	0.000164	0.00135	CcSEcCtD
Metyrosine—TH—Metabolism—HSD17B1—prostate cancer	0.000163	0.00161	CbGpPWpGaD
Metyrosine—Anaemia—Capecitabine—prostate cancer	0.000162	0.00134	CcSEcCtD
Metyrosine—Eosinophilia—Doxorubicin—prostate cancer	0.000161	0.00133	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.00016	0.00158	CbGpPWpGaD
Metyrosine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000158	0.0013	CcSEcCtD
Metyrosine—Diarrhoea—Estradiol—prostate cancer	0.000157	0.0013	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—SERPINE1—prostate cancer	0.000154	0.00153	CbGpPWpGaD
Metyrosine—Asthenia—Mitoxantrone—prostate cancer	0.000154	0.00127	CcSEcCtD
Metyrosine—Fatigue—Etoposide—prostate cancer	0.000154	0.00127	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000153	0.00151	CbGpPWpGaD
Metyrosine—Dysuria—Doxorubicin—prostate cancer	0.000152	0.00125	CcSEcCtD
Metyrosine—Acetaminophen—CYP2E1—prostate cancer	0.000152	0.0208	CrCbGaD
Metyrosine—Dry mouth—Docetaxel—prostate cancer	0.000151	0.00125	CcSEcCtD
Metyrosine—Acetaminophen—CYP1A1—prostate cancer	0.00015	0.0205	CrCbGaD
Metyrosine—Haematuria—Epirubicin—prostate cancer	0.000149	0.00123	CcSEcCtD
Metyrosine—Confusional state—Docetaxel—prostate cancer	0.000149	0.00123	CcSEcCtD
Metyrosine—Anxiety—Capecitabine—prostate cancer	0.000149	0.00123	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000147	0.00146	CbGpPWpGaD
Metyrosine—Feeling abnormal—Etoposide—prostate cancer	0.000147	0.00121	CcSEcCtD
Metyrosine—Diarrhoea—Mitoxantrone—prostate cancer	0.000147	0.00121	CcSEcCtD
Metyrosine—Dry mouth—Capecitabine—prostate cancer	0.000146	0.00121	CcSEcCtD
Metyrosine—Vomiting—Estradiol—prostate cancer	0.000146	0.0012	CcSEcCtD
Metyrosine—Gastrointestinal pain—Etoposide—prostate cancer	0.000146	0.0012	CcSEcCtD
Metyrosine—TH—Metabolism—B4GALT4—prostate cancer	0.000145	0.00144	CbGpPWpGaD
Metyrosine—TH—Metabolism—HPGD—prostate cancer	0.000145	0.00144	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Docetaxel—prostate cancer	0.000145	0.00119	CcSEcCtD
Metyrosine—Anaemia—Prednisone—prostate cancer	0.000145	0.00119	CcSEcCtD
Metyrosine—Confusional state—Capecitabine—prostate cancer	0.000145	0.00119	CcSEcCtD
Metyrosine—Headache—Estradiol—prostate cancer	0.000144	0.00119	CcSEcCtD
Metyrosine—Urticaria—Etoposide—prostate cancer	0.000142	0.00117	CcSEcCtD
Metyrosine—Abdominal pain—Etoposide—prostate cancer	0.000141	0.00116	CcSEcCtD
Metyrosine—Thrombocytopenia—Capecitabine—prostate cancer	0.00014	0.00116	CcSEcCtD
Metyrosine—Oedema peripheral—Epirubicin—prostate cancer	0.000139	0.00114	CcSEcCtD
Metyrosine—Haematuria—Doxorubicin—prostate cancer	0.000138	0.00114	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000137	0.00136	CbGpPWpGaD
Metyrosine—Nausea—Estradiol—prostate cancer	0.000137	0.00113	CcSEcCtD
Metyrosine—TH—Metabolism—TNFRSF21—prostate cancer	0.000136	0.00135	CbGpPWpGaD
Metyrosine—Vomiting—Mitoxantrone—prostate cancer	0.000136	0.00112	CcSEcCtD
Metyrosine—Headache—Mitoxantrone—prostate cancer	0.000134	0.00111	CcSEcCtD
Metyrosine—Insomnia—Docetaxel—prostate cancer	0.000134	0.0011	CcSEcCtD
Metyrosine—Anxiety—Prednisone—prostate cancer	0.000133	0.00109	CcSEcCtD
Metyrosine—TH—Metabolism—MTAP—prostate cancer	0.000133	0.00132	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP7B1—prostate cancer	0.000133	0.00132	CbGpPWpGaD
Metyrosine—Hypersensitivity—Etoposide—prostate cancer	0.000131	0.00108	CcSEcCtD
Metyrosine—Insomnia—Capecitabine—prostate cancer	0.00013	0.00107	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.00013	0.00128	CbGpPWpGaD
Metyrosine—TH—Metabolism—SULT1E1—prostate cancer	0.000129	0.00128	CbGpPWpGaD
Metyrosine—TH—Metabolism—SRD5A1—prostate cancer	0.000129	0.00128	CbGpPWpGaD
Metyrosine—Oedema peripheral—Doxorubicin—prostate cancer	0.000128	0.00106	CcSEcCtD
Metyrosine—Asthenia—Etoposide—prostate cancer	0.000128	0.00105	CcSEcCtD
Metyrosine—Fatigue—Docetaxel—prostate cancer	0.000128	0.00105	CcSEcCtD
Metyrosine—Nausea—Mitoxantrone—prostate cancer	0.000127	0.00105	CcSEcCtD
Metyrosine—Fatigue—Capecitabine—prostate cancer	0.000124	0.00102	CcSEcCtD
Metyrosine—TH—Metabolism—HSD17B3—prostate cancer	0.000123	0.00122	CbGpPWpGaD
Metyrosine—TH—Metabolism—ACSL4—prostate cancer	0.000123	0.00122	CbGpPWpGaD
Metyrosine—Feeling abnormal—Docetaxel—prostate cancer	0.000122	0.00101	CcSEcCtD
Metyrosine—Diarrhoea—Etoposide—prostate cancer	0.000122	0.001	CcSEcCtD
Metyrosine—Gastrointestinal pain—Docetaxel—prostate cancer	0.000121	0.000998	CcSEcCtD
Metyrosine—TH—Metabolism—UMPS—prostate cancer	0.000118	0.00117	CbGpPWpGaD
Metyrosine—TH—Metabolism—ARG2—prostate cancer	0.000118	0.00117	CbGpPWpGaD
Metyrosine—TH—Metabolism—PHGDH—prostate cancer	0.000118	0.00117	CbGpPWpGaD
Metyrosine—Feeling abnormal—Capecitabine—prostate cancer	0.000118	0.000974	CcSEcCtD
Metyrosine—Gastrointestinal pain—Capecitabine—prostate cancer	0.000117	0.000966	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—PTEN—prostate cancer	0.000117	0.00116	CbGpPWpGaD
Metyrosine—Abdominal pain—Docetaxel—prostate cancer	0.000117	0.000965	CcSEcCtD
Metyrosine—TH—Metabolism—LDHB—prostate cancer	0.000116	0.00115	CbGpPWpGaD
Metyrosine—Insomnia—Prednisone—prostate cancer	0.000116	0.000952	CcSEcCtD
Metyrosine—Urticaria—Capecitabine—prostate cancer	0.000114	0.000939	CcSEcCtD
Metyrosine—TH—Metabolism—CYP3A5—prostate cancer	0.000114	0.00113	CbGpPWpGaD
Metyrosine—Abdominal pain—Capecitabine—prostate cancer	0.000113	0.000934	CcSEcCtD
Metyrosine—Vomiting—Etoposide—prostate cancer	0.000113	0.000934	CcSEcCtD
Metyrosine—Anaemia—Epirubicin—prostate cancer	0.000113	0.000932	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—EP300—prostate cancer	0.000112	0.00111	CbGpPWpGaD
Metyrosine—Headache—Etoposide—prostate cancer	0.000112	0.00092	CcSEcCtD
Metyrosine—Fatigue—Prednisone—prostate cancer	0.00011	0.000907	CcSEcCtD
Metyrosine—TH—Metabolism—TCN2—prostate cancer	0.00011	0.00109	CbGpPWpGaD
Metyrosine—TH—Metabolism—UCP3—prostate cancer	0.00011	0.00109	CbGpPWpGaD
Metyrosine—TH—Metabolism—PDHA1—prostate cancer	0.00011	0.00109	CbGpPWpGaD
Metyrosine—TH—Metabolism—GSTA3—prostate cancer	0.00011	0.00109	CbGpPWpGaD
Metyrosine—Hypersensitivity—Docetaxel—prostate cancer	0.000109	0.000899	CcSEcCtD
Metyrosine—Asthenia—Docetaxel—prostate cancer	0.000106	0.000876	CcSEcCtD
Metyrosine—Nausea—Etoposide—prostate cancer	0.000106	0.000872	CcSEcCtD
Metyrosine—Hypersensitivity—Capecitabine—prostate cancer	0.000106	0.000871	CcSEcCtD
Metyrosine—Feeling abnormal—Prednisone—prostate cancer	0.000105	0.000867	CcSEcCtD
Metyrosine—TH—Metabolism—HSD3B1—prostate cancer	0.000105	0.00104	CbGpPWpGaD
Metyrosine—TH—Metabolism—SLC22A3—prostate cancer	0.000105	0.00104	CbGpPWpGaD
Metyrosine—Anaemia—Doxorubicin—prostate cancer	0.000105	0.000863	CcSEcCtD
Metyrosine—Gastrointestinal pain—Prednisone—prostate cancer	0.000104	0.000861	CcSEcCtD
Metyrosine—Anxiety—Epirubicin—prostate cancer	0.000104	0.000856	CcSEcCtD
Metyrosine—Asthenia—Capecitabine—prostate cancer	0.000103	0.000848	CcSEcCtD
Metyrosine—Dry mouth—Epirubicin—prostate cancer	0.000102	0.00084	CcSEcCtD
Metyrosine—Urticaria—Prednisone—prostate cancer	0.000102	0.000836	CcSEcCtD
Metyrosine—Diarrhoea—Docetaxel—prostate cancer	0.000101	0.000835	CcSEcCtD
Metyrosine—Abdominal pain—Prednisone—prostate cancer	0.000101	0.000832	CcSEcCtD
Metyrosine—Confusional state—Epirubicin—prostate cancer	0.000101	0.00083	CcSEcCtD
Metyrosine—TH—Metabolism—TBXAS1—prostate cancer	0.000101	0.000997	CbGpPWpGaD
Metyrosine—TH—Metabolism—GSTA4—prostate cancer	0.000101	0.000997	CbGpPWpGaD
Metyrosine—Diarrhoea—Capecitabine—prostate cancer	9.82e-05	0.000808	CcSEcCtD
Metyrosine—TH—Metabolism—GSTA2—prostate cancer	9.81e-05	0.000971	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Epirubicin—prostate cancer	9.79e-05	0.000806	CcSEcCtD
Metyrosine—TH—Metabolism—SULT1A1—prostate cancer	9.69e-05	0.000959	CbGpPWpGaD
Metyrosine—TH—Metabolism—ABCG5—prostate cancer	9.69e-05	0.000959	CbGpPWpGaD
Metyrosine—Anxiety—Doxorubicin—prostate cancer	9.61e-05	0.000792	CcSEcCtD
Metyrosine—Acetaminophen—CYP3A4—prostate cancer	9.57e-05	0.0131	CrCbGaD
Metyrosine—TH—Metabolism—GSTA1—prostate cancer	9.46e-05	0.000937	CbGpPWpGaD
Metyrosine—Dry mouth—Doxorubicin—prostate cancer	9.43e-05	0.000777	CcSEcCtD
Metyrosine—Vomiting—Docetaxel—prostate cancer	9.42e-05	0.000776	CcSEcCtD
Metyrosine—Hypersensitivity—Prednisone—prostate cancer	9.42e-05	0.000775	CcSEcCtD
Metyrosine—Acetaminophen—PTGS2—prostate cancer	9.37e-05	0.0128	CrCbGaD
Metyrosine—TH—Metabolism—HSD3B2—prostate cancer	9.36e-05	0.000927	CbGpPWpGaD
Metyrosine—TH—Metabolism—NAT2—prostate cancer	9.36e-05	0.000927	CbGpPWpGaD
Metyrosine—TH—Metabolism—GSTO1—prostate cancer	9.36e-05	0.000927	CbGpPWpGaD
Metyrosine—Confusional state—Doxorubicin—prostate cancer	9.32e-05	0.000768	CcSEcCtD
Metyrosine—Headache—Docetaxel—prostate cancer	9.28e-05	0.000765	CcSEcCtD
Metyrosine—Asthenia—Prednisone—prostate cancer	9.17e-05	0.000755	CcSEcCtD
Metyrosine—Vomiting—Capecitabine—prostate cancer	9.12e-05	0.000751	CcSEcCtD
Metyrosine—Thrombocytopenia—Doxorubicin—prostate cancer	9.05e-05	0.000746	CcSEcCtD
Metyrosine—Insomnia—Epirubicin—prostate cancer	9.04e-05	0.000744	CcSEcCtD
Metyrosine—Headache—Capecitabine—prostate cancer	8.99e-05	0.00074	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—IL6—prostate cancer	8.97e-05	0.000889	CbGpPWpGaD
Metyrosine—TH—Metabolism—PLCB2—prostate cancer	8.97e-05	0.000888	CbGpPWpGaD
Metyrosine—TH—Metabolism—LRP2—prostate cancer	8.97e-05	0.000888	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP2C18—prostate cancer	8.97e-05	0.000888	CbGpPWpGaD
Metyrosine—Ibuprofen—CYP2C19—prostate cancer	8.94e-05	0.0122	CrCbGaD
Metyrosine—Nausea—Docetaxel—prostate cancer	8.8e-05	0.000725	CcSEcCtD
Metyrosine—TH—Metabolism—P4HB—prostate cancer	8.8e-05	0.000871	CbGpPWpGaD
Metyrosine—Diarrhoea—Prednisone—prostate cancer	8.74e-05	0.00072	CcSEcCtD
Metyrosine—Fatigue—Epirubicin—prostate cancer	8.62e-05	0.00071	CcSEcCtD
Metyrosine—TH—Metabolism—SLC22A1—prostate cancer	8.56e-05	0.000847	CbGpPWpGaD
Metyrosine—Nausea—Capecitabine—prostate cancer	8.52e-05	0.000702	CcSEcCtD
Metyrosine—Insomnia—Doxorubicin—prostate cancer	8.36e-05	0.000689	CcSEcCtD
Metyrosine—TH—Metabolism—SULT2A1—prostate cancer	8.34e-05	0.000826	CbGpPWpGaD
Metyrosine—Feeling abnormal—Epirubicin—prostate cancer	8.24e-05	0.000678	CcSEcCtD
Metyrosine—TH—Metabolism—MED12—prostate cancer	8.2e-05	0.000812	CbGpPWpGaD
Metyrosine—Gastrointestinal pain—Epirubicin—prostate cancer	8.17e-05	0.000673	CcSEcCtD
Metyrosine—TH—Metabolism—GNG5—prostate cancer	8.14e-05	0.000806	CbGpPWpGaD
Metyrosine—Vomiting—Prednisone—prostate cancer	8.13e-05	0.000669	CcSEcCtD
Metyrosine—Headache—Prednisone—prostate cancer	8.01e-05	0.000659	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—TP53—prostate cancer	8e-05	0.000793	CbGpPWpGaD
Metyrosine—Fatigue—Doxorubicin—prostate cancer	7.97e-05	0.000657	CcSEcCtD
Metyrosine—Urticaria—Epirubicin—prostate cancer	7.94e-05	0.000654	CcSEcCtD
Metyrosine—Abdominal pain—Epirubicin—prostate cancer	7.9e-05	0.000651	CcSEcCtD
Metyrosine—TH—Metabolism—NCOA3—prostate cancer	7.84e-05	0.000776	CbGpPWpGaD
Metyrosine—Feeling abnormal—Doxorubicin—prostate cancer	7.62e-05	0.000628	CcSEcCtD
Metyrosine—Nausea—Prednisone—prostate cancer	7.59e-05	0.000625	CcSEcCtD
Metyrosine—Gastrointestinal pain—Doxorubicin—prostate cancer	7.56e-05	0.000623	CcSEcCtD
Metyrosine—TH—Metabolism—HPGDS—prostate cancer	7.48e-05	0.000741	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP2C19—prostate cancer	7.43e-05	0.000736	CbGpPWpGaD
Metyrosine—Hypersensitivity—Epirubicin—prostate cancer	7.36e-05	0.000606	CcSEcCtD
Metyrosine—Urticaria—Doxorubicin—prostate cancer	7.35e-05	0.000605	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—IL6—prostate cancer	7.33e-05	0.000726	CbGpPWpGaD
Metyrosine—Abdominal pain—Doxorubicin—prostate cancer	7.31e-05	0.000602	CcSEcCtD
Metyrosine—TH—Metabolism—GSTT1—prostate cancer	7.25e-05	0.000718	CbGpPWpGaD
Metyrosine—TH—Metabolism—ACHE—prostate cancer	7.25e-05	0.000718	CbGpPWpGaD
Metyrosine—Asthenia—Epirubicin—prostate cancer	7.17e-05	0.000591	CcSEcCtD
Metyrosine—TH—Metabolism—CYP2A6—prostate cancer	7.17e-05	0.00071	CbGpPWpGaD
Metyrosine—TH—Metabolism—AKR1C3—prostate cancer	6.97e-05	0.000691	CbGpPWpGaD
Metyrosine—TH—Metabolism—PRKACB—prostate cancer	6.94e-05	0.000687	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP17A1—prostate cancer	6.87e-05	0.00068	CbGpPWpGaD
Metyrosine—Diarrhoea—Epirubicin—prostate cancer	6.84e-05	0.000563	CcSEcCtD
Metyrosine—Hypersensitivity—Doxorubicin—prostate cancer	6.81e-05	0.000561	CcSEcCtD
Metyrosine—Asthenia—Doxorubicin—prostate cancer	6.63e-05	0.000546	CcSEcCtD
Metyrosine—TH—Metabolism—NCOA2—prostate cancer	6.54e-05	0.000648	CbGpPWpGaD
Metyrosine—Vomiting—Epirubicin—prostate cancer	6.35e-05	0.000523	CcSEcCtD
Metyrosine—Diarrhoea—Doxorubicin—prostate cancer	6.33e-05	0.000521	CcSEcCtD
Metyrosine—Headache—Epirubicin—prostate cancer	6.26e-05	0.000516	CcSEcCtD
Metyrosine—TH—Metabolism—SLC5A5—prostate cancer	6.24e-05	0.000618	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP2E1—prostate cancer	6.1e-05	0.000604	CbGpPWpGaD
Metyrosine—TH—Metabolism—NQO1—prostate cancer	6.03e-05	0.000597	CbGpPWpGaD
Metyrosine—Nausea—Epirubicin—prostate cancer	5.94e-05	0.000489	CcSEcCtD
Metyrosine—Vomiting—Doxorubicin—prostate cancer	5.88e-05	0.000484	CcSEcCtD
Metyrosine—TH—Metabolism—CYP3A4—prostate cancer	5.88e-05	0.000582	CbGpPWpGaD
Metyrosine—Headache—Doxorubicin—prostate cancer	5.79e-05	0.000477	CcSEcCtD
Metyrosine—TH—Metabolism—CYP1B1—prostate cancer	5.78e-05	0.000572	CbGpPWpGaD
Metyrosine—TH—Metabolism—GGT1—prostate cancer	5.6e-05	0.000554	CbGpPWpGaD
Metyrosine—Ibuprofen—PTGS2—prostate cancer	5.57e-05	0.00762	CrCbGaD
Metyrosine—TH—Metabolism—NCOA1—prostate cancer	5.51e-05	0.000546	CbGpPWpGaD
Metyrosine—Nausea—Doxorubicin—prostate cancer	5.49e-05	0.000452	CcSEcCtD
Metyrosine—TH—Metabolism—CYP19A1—prostate cancer	5.43e-05	0.000538	CbGpPWpGaD
Metyrosine—TH—Metabolism—RXRA—prostate cancer	5.24e-05	0.000519	CbGpPWpGaD
Metyrosine—TH—Metabolism—COMT—prostate cancer	5.05e-05	0.0005	CbGpPWpGaD
Metyrosine—TH—Metabolism—GSTP1—prostate cancer	5.03e-05	0.000498	CbGpPWpGaD
Metyrosine—TH—Metabolism—ITPR1—prostate cancer	4.95e-05	0.00049	CbGpPWpGaD
Metyrosine—TH—Metabolism—TYMS—prostate cancer	4.67e-05	0.000463	CbGpPWpGaD
Metyrosine—TH—Metabolism—GSTM1—prostate cancer	4.62e-05	0.000458	CbGpPWpGaD
Metyrosine—TH—Metabolism—LPL—prostate cancer	4.54e-05	0.000449	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP1A1—prostate cancer	4.38e-05	0.000434	CbGpPWpGaD
Metyrosine—TH—Metabolism—ERCC2—prostate cancer	4.34e-05	0.00043	CbGpPWpGaD
Metyrosine—TH—Metabolism—MTHFR—prostate cancer	4.08e-05	0.000404	CbGpPWpGaD
Metyrosine—TH—Metabolism—PPARA—prostate cancer	4.01e-05	0.000397	CbGpPWpGaD
Metyrosine—TH—Metabolism—CAV1—prostate cancer	3.77e-05	0.000373	CbGpPWpGaD
Metyrosine—TH—Metabolism—PIK3CG—prostate cancer	3.43e-05	0.00034	CbGpPWpGaD
Metyrosine—TH—Metabolism—INS—prostate cancer	3.25e-05	0.000322	CbGpPWpGaD
Metyrosine—TH—Metabolism—CREBBP—prostate cancer	3.18e-05	0.000315	CbGpPWpGaD
Metyrosine—TH—Metabolism—PIK3CD—prostate cancer	3.02e-05	0.000299	CbGpPWpGaD
Metyrosine—TH—Metabolism—NOS3—prostate cancer	2.85e-05	0.000282	CbGpPWpGaD
Metyrosine—TH—Metabolism—PIK3CB—prostate cancer	2.63e-05	0.00026	CbGpPWpGaD
Metyrosine—TH—Metabolism—PTGS2—prostate cancer	2.6e-05	0.000258	CbGpPWpGaD
Metyrosine—TH—Metabolism—PTEN—prostate cancer	2.27e-05	0.000225	CbGpPWpGaD
Metyrosine—TH—Metabolism—EP300—prostate cancer	2.17e-05	0.000215	CbGpPWpGaD
Metyrosine—TH—Metabolism—PIK3CA—prostate cancer	1.6e-05	0.000159	CbGpPWpGaD
Metyrosine—TH—Metabolism—AKT1—prostate cancer	1.31e-05	0.00013	CbGpPWpGaD
